CMS Okays Payment for Novel AI Prostate Test
Medicare will now cover an AI-based test for prostate cancer that predicts which men will benefit from androgen deprivation therapy. The Centers for Medicare & Medicare Services approved the payment rate for ArteraAI as a clinical diagnostic test. The test improves risk stratification and personalizes treatment. It combines a patient’s clinical and pathologic information into…